GW Pharmaceuticals Plc

( )
GWPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc 24.50%4.981.6%$86.29m
JAZZJazz Pharmaceuticals Plc -4.07%95.682.3%$85.16m
VRXValeant Pharmaceuticals International, Inc. -11.32%13.7514.1%$80.91m
PRGOPerrigo Co. Plc -6.03%45.196.8%$78.90m
CTLTCatalent, Inc. -7.68%47.962.2%$68.67m
UTHRUnited Therapeutics Corp. -0.98%93.9014.3%$68.29m
AXSMAxsome Therapeutics, Inc. -5.17%55.791.9%$64.25m
ICLRICON plc -2.79%132.204.2%$63.45m
HZNPHorizon Therapeutics Plc 1.94%30.206.5%$62.30m
GWPHGW Pharmaceuticals Plc -2.94%85.006.2%$54.99m
ICPTIntercept Pharmaceuticals, Inc. -7.24%58.4016.8%$39.26m
SAGESAGE Therapeutics, Inc. -6.86%26.758.6%$35.10m
PBHPrestige Consumer Healthcare, Inc. 1.50%37.234.0%$32.56m
PCRXPacira Biosciences, Inc. -3.91%32.2210.4%$30.88m
ZGNXZogenix, Inc. -6.59%23.109.2%$30.31m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.